Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Kinley
J. Kinley
Takeda Pharmaceutical Company
Immunology
Brentuximab vedotin
Medicine
Internal medicine
relapsed refractory
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
BRENTUXIMAB VEDOTIN POPULATION PHARMACOKINETIC (POPPK) MODELLING IN ADULT AND PAEDIATRIC PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) HEMATOLOGIC MALIGNANCIES
2019
Hematological Oncology
Ajit Suri
Diane R. Mould
Gregory Song
J. Kinley
Karthik Venkatakrishnan
Show All
Source
Cite
Save
Citations (0)
A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE-CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL)
2017
Hematological Oncology
Franco Locatelli
C. Mauz-Koerholz
Kathleen Neville
A. Llort
Auke Beishuizen
Stephen Daw
Marta Pillon
N. Aladjidi
Thomas Klingebiel
Judith Landman-Parker
A. Medina Sanson
Keith J. August
D. Huebner
J. Sachs
K. Hoffman
J. Kinley
S. Song
G. Song
S. Zhang
Lia Gore
Show All
Source
Cite
Save
Citations (5)
1